#tumor — Monday, July 13, 2026 (1 items)
| 0 | 💬 0 |
Repurposed ethoxzolamide reprograms antitumor immunity through beta-TrCP-dependent PD-L1 ubiquitination.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-07-13 | #cancer #immunotherapy #tumor #ubiquitination #checkpoint |